NASH comment in 10Q
Post# of 148187
(Total Views: 543)
Posted On: 01/09/2020 4:30:34 PM
NASH comment in 10Q
Says, "leronlimab may control the devastating effects of liver fibrosis". It's still unclear to me whether leronlimab has the potential to reverse fibrosis or not.
We've discussed this in the past and I believe it was trding who pointed to a Nader quote along those lines but it's still something I would like Nader to explicitly address. Reversing fibrosis is a big goal of NASH drugs and whether or not leronlimab can do that will likely be a large factor in how big the drug's impact can be in the NASH space.
Says, "leronlimab may control the devastating effects of liver fibrosis". It's still unclear to me whether leronlimab has the potential to reverse fibrosis or not.
We've discussed this in the past and I believe it was trding who pointed to a Nader quote along those lines but it's still something I would like Nader to explicitly address. Reversing fibrosis is a big goal of NASH drugs and whether or not leronlimab can do that will likely be a large factor in how big the drug's impact can be in the NASH space.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼